We are pleased to share the latest issue of LEAP magazine where the Alberta Cancer Foundation (ACF) explores the concept of ‘Survivorship.’ For many Albertans facing cancer, their journey doesn’t end when treatment does. This issue highlights some of the latest resources, studies and supports in place that help cancer survivors and ‘thrivers’ navigate their new normal.
We are pleased to share the latest Winter 2021 Progress Report from the Alberta Cancer Foundation (ACF). ACF is proud to share some examples of the exciting work taking place right here in Alberta.
The Phase I-II Niacin in Neuro Glioblastoma trial is scheduled to open at the Tom Baker Cancer Centre in the Spring of 2021. This trial is based on the University of Calgary researchers' discovery of a new tactic to stop the growth of the deadly brain cancer. Findings indicate the body may be the ultimate weapon against glioblastoma, but it needs help.
Alberta Cancer Clinical Trials (ACCT) works with researchers and expert data analysts within Cancer Research & Analytics (CR&A), in Cancer Care Alberta at Alberta Health Services. CR&A has just published an overview of its portfolio, which describes the broad range of work underway across the entire cancer continuum, from prevention through to survivorship. Come meet the teams and see the innovative research being conducted to improve the outcomes and experiences for people in Alberta facing cancer.
